MedPath

ACT RALOXIFENE

ACT RALOXIFENE

Approved
DIN Number

02358840

Drug Class

Human

Market Date

Jun 19, 2012

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02358840
AIG Number0151607001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G03XC01 RALOXIFENE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:16.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

RALOXIFENE HYDROCHLORIDEActive
Strength: 60 MG
Monograph: RALOXIFENE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.